Morphine-modulated mast cell migration and proliferation during early stages of zymosan-induced peritonitis in CBA mice. Folia biologica (Kraków) 59: 99-106. We have previously shown that supplementation of inflammation-inducing zymosan with a high dose of morphine inhibits peritoneal influx of leukocytes in Swiss, C57C3H, Balb/c, and C57BL/6 strains but not in CBA mice. We have also reported that the different pattern of the response to morphine treatment might be, at least partially, due to the inter-strain differences in the peritoneal mast cell (P-MC) number (high in CBA mice versus other strains) and P-MC specific features (high sensitivity to degranulation upon morphine treatment in CBA mice).
Mast cells and their numerous mediators are considered to play an important role in many aspects of natural and acquired immunity (CRIVELLATO & RIBATTI 2010; STELEKATI et al. 2007 ). Experimental peritonitis induced by i.p. injection of a sterile stimulant such as zymosan represents a convenient model for studies on mast cell involvement in inflammation (KOLACZKOWSKA et al. 2008a; KOLACZKOWSKA et al. 2008b; PLYTYCZ & NATORSKA 2002; NATORSKA & PLYTYCZ 2005; STANKIEWICZ et al. 2004; KOLACZKOWSKA et al. 2001a) . It was previously shown that peritoneal mast cells (P-MCs) are key effector cells in the initiation of zymosan-induced peritonitis and modulate its further course as confirmed by experiments conducted on genetically mast cell-deficient mice (KOLACZKOWSKA et al. 2001b) .
It was also reported that the supplementation of zymosan with a high dose of morphine, besides its analgesic effects, inhibits influx of inflammatory leukocytes into peritoneum in four out of five investigated strains of mice (Swiss, C57C3H, Balb/c, and C57BL strains but not in CBA mice) (NATORSKA & PLYTYCZ 2005) . Moreover, it was documented that the anti-inflammatory effects of morphine in the four strains of mice are connected with morphine-induced desensitization of leukocyte receptors for some chemotactic factors (SZABO et al. 2002) . As stated above, in the CBA strain the influx of peritoneal leukocytes (PTLs) was not inhibited at any investigated time point _______________________________________ *Supported by grant from BW/IZ/54/2006 (Jagiellonian University) and KBN grant N N303 3596 332. and 8 hours after induction of peritonitis it was even enhanced in mice co-injected with morphine (NATORSKA & PLYTYCZ 2005) . The different effects of morphine on CBA versus the other investigated murine strains might be linked to inter-strain differences in the number and characteristics of PMCs. CBA mast cells, in contrast to Swiss mice, are much more numerous and highly prone to degranulation by morphine (STANKIEWICZ et al. 2004) . Moreover, our preliminary studies revealed that the morphine treatment significantly increased P-MC accumulation despite their degranulation. These results prompted us to study the effects of morphine on peritoneal mast cell migration and proliferation in CBA mice during zymosan-induced peritonitis modulated by morphine.
Materials and Methods

Animals
The ethical guidelines of the local committee on animal care were followed throughout the experiments (license no. 23/OP/2005 and 11/2010).
Adult males of the CBA strain (4-6 week-old, 23-25 g) purchased from the Unit of Laboratory Animals (Collegium Medicum, Jagiellonian University, Kraków, Poland) were used in the present experiments. Mice were housed 5 per cage under strictly controlled conditions (at a room temperature of 20±2°C, 12h/12h light-dark cycle with food and water available ad libitum).
Inflammatory models and drug treatment
Peritoneal inflammation was induced according to DOHERTY et al. (1985) . Zymosan A (SigmaAldrich, Co., London, UK) was freshly prepared (2 mg/ml) in sterile 0.9% w/v saline and 40 mg/kg b.w. (0.5 ml / 25 g b.w.) was administrated i.p. Animals were either injected with zymosan (Z), morphine sulphate (20 mg/kg b.w.; M) (Polfa, Kutno, Poland) or zymosan supplemented with morphine (ZM). One group of animals was left untreated (intact mice, INT). At the selected time points, animals were killed by cervical dislocation.
Preparation of peritoneal leukocytes and fluids
The peritoneal cavity was lavaged with 1 ml of PBS, and after a 30-s gentle manual massage exudate was retrieved and centrifuged at 1200 rpm for 10 minutes. The cells were subsequently used for counting and mast cell separation.
Cell counts
Mast cell counts were done with a haemocytometer following staining with safranin O solution (0.1% safranine in 0.1% acetic acid) (GODFRAIND et al. 1998) .
Cytokine content
The peritoneal exudate content of mouse KC (a murine CXC chemokine) was measured by application of an ELISA kit (R&D System, Minneapolis, USA). The assay was carried out as indicated by the manufacturer.
Mast cell separation
Mast cells were obtained in a high state of purity from mouse peritoneal washings by centrifugation in metrizamide density gradients (JOZAKI et al. 1990 ) (opioid receptor binding study) or using MACS (Magnetic Activated Cells Sorting) Technology (Miltenyi Biotec GmbH, Germany) according to the manufacturer's procedure. Briefly, in the latter method total peritoneal leukocytes collected from each mouse were counted, adjusted to 1x10 7 cells per 100 Fl and incubated with an antibody against c-kit (CD 117) receptor (present on mature MCs) conjugated with FITC. After washing, the unbound antibodies were removed and the cells were incubated with anti-FITC MicroBeads. Then the cells were washed and subjected to magnetic separation with MS (Middle Scale) Column. In the magnetic field, the bead-unlabeled cell fraction passed through. In contrast, magnetically labelled cells attached to the magnetic column and were flushed out from the column after removing the magnet. The pure MCs were used for the migration and proliferation assays.
â-Hexosaminidase assay
Release of the mast cell granule component â-hexosaminidase enzyme was used for detection of mast cells degranulation (DEMO et al. 1999) . To determine â-hexosaminidase activity, cells were lysed on ice with Tyrode's buffer containing 0.1% (vol/vol) Triton X-100 for 5 min and then spun at 5000xg. The supernatant (100 Fl) was collected and incubated with 2mM of the substrate solution (1.3 mg/ml of p-nitrophenyl-N-acetyl-b-D--glucosaminide (Sigma-Aldrich) in 100 Fl of 40 m M citrate buffer (pH 4.5) for 15 min at 37°C. The reaction was terminated by the addition of 100 ml of 0.2 M NaOH/0.2 M glycine. Absorbance was read at 440 nm in an enzyme-linked immunosorbent assay reader, and the amount of exocytosis was expressed as the percentage of total â-hexosaminidase activity present in cells.
Opioid receptor binding
Metrizamide-purified peritoneal mast cells were washed in RPMI medium and incubated for 60 min with morphine (10 -8 M) -a receptor opioid agonist; and the control samples were incubated with RPMI. In some experiments the samples were preincubated with RPMI or with antagonists of opioid receptors: for 60 min with Pertussis toxin (1 Fg/ml, Sigma-Aldrich) (EMADI-KHIAV et al. 1995) , 20 min with naltrexon (10 -8 M, Sigma-Aldrich) (GRIMM et al. 1998a; GRIMM et al. 1998b) or 60 min with cromolyn -a mast cell membrane stabilizing agent (10 -4 M, Sigma-Aldrich) (TANIZAKI et al. 1992 ). After the above incubation the samples were centrifuged (10 min at 400xg) and then cell degranulation was assessed morphologically according to LEVI-SCHAFFER et al. (2000) on safranine-stained cytospin preparations. Moreover, levels of histamine released to supernatants was assessed by enzyme-linked immunosorbent assay (ICM Pharmaceuticals, Inc., Cost Mesa, CA, USA) and calculated according to the VERBSKY et al. (1996) formula: % histamine released = (histamine released by the inducer/total histamine content) x 100.
Mast cell migration assay P-MC migratory activity was assessed by using a 48-well microchemotaxis chamber (Neuro Probe, Inc., Maryland, USA). The lower wells of the apparatus were filled with either 27 Fl of morphine (10 -8 M) dissolved in culture medium (RPMI) or RPMI alone (as a control of random migration) and then covered with nitro-cellulose filters (10 Fm pore size; Nucleopore membrane, Neuro Probe Inc.). The upper wells were filled with 50 Fl of peritoneal mast cell suspension (5x10 5 cells/ml) separated on the MACS Technology. Some cells were exposed to 5 minutes of preincubation with two different concentrations of naltrexon (either 10 -3 M or 10 -8 M); the controls were preincubated with RPMI. After 3-hour incubation at 37 o C the cells remaining on the upper surface of the filter were removed. The filters were fixed in 4% buffered formalin, stained with Harris's haematoxylin (40 min), washed in water (10 min) and cleared in xylene (15 min) (all from POCh, Gliwice, Poland). The cells migrating through the filter were counted using a 40x objective on three to four levels and pooled. The counting procedure was repeated in three independent fields, and the mean value was calculated for each well. The mean values from triplicate wells of each sample (within the same filter) were used for statistical analysis.
Mast cell proliferation
For analysis of cell proliferation by flow cytometry, the separated mast cells were adjusted to a concentration of 5x10 5 cells/ml and incubated with propidium iodide (PI) (Bender MedSystem, Vienna, Austria) according to BLACKLIDGE and BIDWELL (1993) . After 10 minutes the samples were analyzed on a FACScan flow cytometer (Becton Dickinson Immunocytometry System, USA) to assess the cell cycle DNA profile. Orange emission from PI was collected through the FL-2 channel. Intensity of propidium iodide-derived FL-2 fluorescence is proportional to cell DNA content. The resulting files of DNA histograms were analysed using WinMDI 2.8 software (Joe Trotter, http://facs.scripps.edu).
Statistical analysis
All data were expressed as means ± SE from three independent experiments. The numbers of cells and kinetic changes of each parameter were compared by analysis of variance (ANOVA) followed by post hoc Tukey's test. The differences were considered statistically significant at p<0.05.
Results and Discussion
It has been previously shown that the supplementation of a proinflammatory agent with a high dose of morphine (20 mg/kg of body weight) not only attenuated pain but also inhibited influx of polymorphonuclear leukocytes (PMNs) to the focus of inflammation during zymosan-induced peritonitis in mice (PLYTYCZ & NATORSKA 2002) . These anti-inflammatory effects of morphine were recorded in most strains of mice (C57C3H, Swiss, Balb/c, C57BL/6) (PLYTYCZ & NATORSKA 2002) except CBA (NATORSKA & PLYTYCZ 2005) . The latter strain revealed high levels of PMN accumulation both after zymosan and zymosan-supplemented with morphine i.p. co-injection (Fig. 1) .
Mast Cell Migration and Proliferation in Mice STANKIEWICZ and co-writers (2004) formulated a hypothesis that different responses to supplementation of peritonitis-inducing agent with morphine may depend, at least partially, on the inter-strain differences in peritoneal MC (P-MC) number and their characteristics. This was based on observation that in contrast to Swiss mice, the CBA P-MCs are not only much more numerous (STANKIEWICZ et al. 2001 ) but also very sensitive to morphine-induced degranulation and histamine release leading to induction of inflammatory response (STANKIEWICZ et al. 2004) .
In current experiments, in Swiss mice, thirty minutes after morphine co-injection with zymosan, P-MC numbers diminished (Fig. 2a) and a concomitant increase in histamine levels in the peritoneal fluid suggests that this was due to their degranulation (Fig. 2b) . Interestingly, in CBA mice the P-MC numbers did not change although some histamine release was observed (Fig. 2b) .
Because of this we decided to extend our observation of P-MCs for the next few hours of peritonitis (Fig. 3) . We detected that in the CBA strain, in contrast to Swiss mice, mast cell numbers significantly increased within the first 4 hours of peritonitis (Fig. 3a) . This increase of P-MCs was connected with their degranulation quantified by â-hexosaminidase release and histamine secretion ( Fig. 3b and 3c, respectively) . Moreover, a murine CXC chemokine KC (equivalent to human CXCL8/IL-8) was detected in zymosan exudates both in Swiss and CBA mice but its level was significantly higher in CBA than Swiss mice at 4 hours of peritonitis (Fig. 3d) . It was previously reported that resident peritoneal MCs play a central role in the production of the KC and mMCP-1 chemokines (mainly for inflammatory neutrophiles and monocytes, respectively) during the acute inflammatory response induced by i.p. injection of zymosan (AJUEBOR et al. 1999) . It is known that chemokines and opiates have the capacity to desensitize chemokine receptors on leukocytes (GRIMM et al. 1998a; GRIMM et al. 1998b) resulting in a significant inhibition of leukocyte infiltration to the focus of inflammation (CHADZINSKA et al. 1999) . Therefore, in the present study the high number of degranulating P-MCs associated with the high-level of KC secretion may suggest that desensitization of chemokine receptors would be even stronger in CBA than in Swiss mice. However, in CBA animals KC production significantly increased from the 4th hour of morphinemodulated peritonitis (most probably as a consequence of high P-MC numbers and their sustained degranulation), leading to continuous leukocyte accumulation from this time on. Therefore even if morphine could have initially impaired neutrophile accumulation, prolonged KC production by continuously migrating and/or proliferating mast cells evoked constant leukocyte influx and counterbalanced the otherwise anti-inflammatory effects of morphine. Mast cell accumulation within inflamed tissue has been described in a number of diseases such as asthma (DOUGHERTY et al. 2010) or rheumatoid arthritis (SHIN et al. 2009 ) but mechanisms of this action are still unclear. An increase of MC could occur by recruitment of mast cell precursors from the circulation followed by their local maturation, local proliferation of resident mast cells, or migration of mature mast cells from adjacent tissues (OKAYAMA & KAWAKAMI 2006; GODFRAIND et al. 1998) . In the latter case this could be caused by MC--derived mediators such as histamine (THURMOND et al. 2004 ), LTB 4 (WELLER et al. 2005 or PGE 2 (WELLER et al. 2007) . Thus in order to verify the cause of P-MC accumulation during morphinemodulated peritonitis we investigated the migratory activity and proliferation of separated P-MC (from the whole population of PTLs) of CBA mice in response to morphine. Morphine alone acted as a strong chemoattractant for P-MC and this effect was not reversed by a specific antagonist of opioid receptors (naltrexon) (Fig. 4) suggesting the opioid--independent action of morphine. Previously, CHADZINSKA et al. (1999) showed that migration of mouse bone marrow cells towards plasma of intact or thioglycollate-treated CB6 mice was enhanced after its in vitro supplementation with morphine sulfate (10 -8 M) in comparison to treatments without the opioid. Moreover, it was observed that opiate compounds, including met-enkephalin and morphine acted as strong chemoattractants for monocytes and neutrophiles and this action was inhibited by the opiate receptor antagonist naloxone (GRIMM et al. 1999a; GRIMM et al. 1998b ). The present experiments showed that opioid receptors expressed on CBA mast cells are insensitive to naltrexone, indicating opioid receptor-independence.
Our in vitro experiments utilizing the specific opiate inhibitors Pertussis toxin (antagonist of G protein receptors), naltrexone (antagonist of opioid receptors) and cromolyn (stabilizer of the mast cell membrane) confirm the hypothesis of receptorindependent mast cell activation by morphine in CBA mice (Fig. 5) . In particular, none of the components reversed mast cell degranulation (Fig. 5a ) nor histamine release (Fig. 5b) induced by morphine. It is known that opiates (including morphine) act on MCs either through opioid receptors that are connected with G proteins (SHEEN et al. 2007; KLINKER et al. 1997) or like some other substances (compound 48/80, substance P, transcription factor E2F80) may activate MC through receptor-independent G-protein manner (BUNDOC & SEIFERT 1997; HAGEMANN et al. 2007; MOUSLI et al. 1990 ) but the molecular mechanisms behind these processes are still unresolved. It was suggested that morphine, cocaine and methadone might become activated into free radicals which produce membrane lipid perturbation and histamine release (DI BELLO et al. 1998) . It was also proposed that substance P and compound 48/80 may stimulate G-proteins by mimicking part of the intracellular loop of G-protein-coupled receptors (MOUSLI et al. 1990) . Therefore, we hypothesize that the sensitivity of opioid receptors to naltrexone is strain-dependent and perhaps related to the characteristics of the local cell subpopulations and/or their maturation.
The increased number of MCs during the inflammatory process may also be induced by their local proliferation regulated by inflammatory cytokines (HU et al. 2007) Here we demonstrate that in CBA mice MCs collected from peritoneum 4 hours after stimulation with either morphine (Fig. 6b) or zymosan co-injected with morphine ( Fig. 6c) show a significant higher proliferation rate in comparison to the untreated mice ( Fig. 6a and d) .
Altogether the results reveal that in CBA mice morphine acts as a chemotactic factor for P-MCs and induces their proliferation. Moreover, it was previously reported that in CBA mice morphine acts as a strong pro-inflammatory agent inducing P-MC degranulation and histamine release (STANKIEWICZ et al. 2004) . Surprisingly, upon morphine treatment the number of P-MCs increases significantly in the focus of inflammation despite their degranulation. Thus, we postulate the following scenario: CBA mast cells degranulate and secrete chemotactic factors (mainly KC acting on inflammatory PMNs and MCP-1 affecting macrophage migration (AJUEBOR et al. 1999 ) but simultaneously their number increases due to MC proliferation. We also cannot exclude that some mast cells may migrate to the focus of inflammation in response to morphine treatment. Chemotactic factors (e.g. KC) secreted by numerous peritoneal mast cells cause continuous leukocyte infiltration to the peritoneum cavity which impairs the anti-inflammatory effect of morphine in CBA mice.
